These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 15703263
1. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins. Day BJ, Kariya C. Toxicol Sci; 2005 May; 85(1):713-9. PubMed ID: 15703263 [Abstract] [Full Text] [Related]
2. Flavin-dependent antioxidant properties of a new series of meso-N,N'-dialkyl-imidazolium substituted manganese(III) porphyrins. Kachadourian R, Johnson CA, Min E, Spasojevic I, Day BJ. Biochem Pharmacol; 2004 Jan 01; 67(1):77-85. PubMed ID: 14667930 [Abstract] [Full Text] [Related]
3. Synthesis and in vitro antioxidant properties of manganese(III) beta-octabromo-meso-tetrakis(4-carboxyphenyl)porphyrin. Kachadourian R, Flaherty MM, Crumbliss AL, Patel M, Day BJ. J Inorg Biochem; 2003 Jul 01; 95(4):240-8. PubMed ID: 12818794 [Abstract] [Full Text] [Related]
4. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase. Kousba A, Soll R, Yee S, Martin M. Drug Metab Dispos; 2007 Dec 01; 35(12):2242-51. PubMed ID: 17881660 [Abstract] [Full Text] [Related]
5. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP. Chem Res Toxicol; 1997 Jan 01; 10(1):91-102. PubMed ID: 9074808 [Abstract] [Full Text] [Related]
6. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea. Oka K, Kitamura S, Tatsumi K. J Pharm Pharmacol; 1996 Sep 01; 48(9):930-2. PubMed ID: 8910855 [Abstract] [Full Text] [Related]
7. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases. Weber GF, Waxman DJ. Arch Biochem Biophys; 1993 Dec 01; 307(2):369-78. PubMed ID: 8274024 [Abstract] [Full Text] [Related]
10. A study on the antioxidant capacities of some benzimidazoles in rat tissues. Can-Eke B, Puskullu MO, Buyukbingol E, Iscan M. Chem Biol Interact; 1998 May 01; 113(1):65-77. PubMed ID: 9630848 [Abstract] [Full Text] [Related]
11. Inhibition studies on the involvement of flavoprotein reductases in menadione- and nitrofurantoin-stimulated oxyradical production by hepatic microsomes of flounder (Platichthys flesus). Lemaire P, Livingstone DR. J Biochem Toxicol; 1994 Apr 01; 9(2):87-95. PubMed ID: 8071949 [Abstract] [Full Text] [Related]
17. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Chun YJ, Kim MY, Guengerich FP. Biochem Biophys Res Commun; 1999 Aug 19; 262(1):20-4. PubMed ID: 10448061 [Abstract] [Full Text] [Related]
18. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450. Nebbia C, Ceppa L, Dacasto M, Carletti M. J Toxicol Environ Health A; 1999 Mar 26; 56(6):433-47. PubMed ID: 10096365 [Abstract] [Full Text] [Related]